Taigen Biopharmaceuticals Holdings Ltd (4157) — Cash Flow-to-Debt Ratio
Taigen Biopharmaceuticals Holdings Ltd (4157) has a Cash Flow-to-Debt Ratio of 0.50x as of December 2025, meaning its operating cash flow of NT$46.51 Million could theoretically repay 1% of its total liabilities (NT$92.38 Million) in one year. Explore 4157 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Taigen Biopharmaceuticals Holdings Ltd Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Taigen Biopharmaceuticals Holdings Ltd across 16 annual periods. Also explore 4157 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Taigen Biopharmaceuticals Holdings Ltd (2010–2025)
Year-by-year debt coverage analysis for Taigen Biopharmaceuticals Holdings Ltd. For market capitalisation and broader financial context, see 4157 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | NT$20.93 Million | NT$92.38 Million | ▲ +112.0% |
| 2024 | -1.88x | NT$-173.09 Million | NT$91.96 Million | ▼ -1106.8% |
| 2023 | 0.19x | NT$20.74 Million | NT$110.94 Million | ▲ +167.7% |
| 2022 | -0.28x | NT$-21.27 Million | NT$76.98 Million | ▼ -106.1% |
| 2021 | 4.52x | NT$629.07 Million | NT$139.11 Million | ▲ +313.4% |
| 2020 | -2.12x | NT$-242.10 Million | NT$114.26 Million | ▲ +19.0% |
| 2019 | -2.62x | NT$-342.52 Million | NT$130.92 Million | ▲ +3.2% |
| 2018 | -2.70x | NT$-254.93 Million | NT$94.36 Million | ▲ +1.1% |
| 2017 | -2.73x | NT$-266.93 Million | NT$97.71 Million | ▼ -164.2% |
| 2016 | -1.03x | NT$-152.83 Million | NT$147.82 Million | ▲ +67.9% |
| 2015 | -3.22x | NT$-592.56 Million | NT$183.86 Million | ▼ -46.8% |
| 2014 | -2.19x | NT$-540.03 Million | NT$246.05 Million | ▼ -59.3% |
| 2013 | -1.38x | NT$-458.46 Million | NT$332.71 Million | ▼ -252.0% |
| 2012 | -0.39x | NT$-141.36 Million | NT$361.15 Million | ▲ +90.0% |
| 2011 | -3.90x | NT$-379.23 Million | NT$97.31 Million | ▼ -10617.6% |
| 2010 | -0.04x | NT$-196.43 Million | NT$5.40 Billion | — |